Board of Pharmacy Specialties
2215 Constitution Avenue, NW
Washington, DC 20037
(202) 429-7591
(202) 429-6304 FAX
www.bpsweb.org
FOR IMMEDIATE RELEASE:
April 2, 2012
Contact:
Steve Scarlata
info@bpsweb.org
202-429-6306
BPS Issues Call for Infectious Diseases and Cardiology Practice Analysis Taskforce Members
During the BPS Board meeting held on March 14, 2012, BPS approved the conduct of role delineation studies in Infectious Diseases and Cardiology. Conducting a role delineation study is a critical step in evaluating a proposed specialty. The purpose of these role delineation studies is to determine whether Infectious Diseases and Cardiology Pharmacy are based upon a specialized knowledge of the pharmaceutical sciences as well as specialized functions routinely performed by practitioners in these proposed specialties.
To begin the role delineation studies in each proposed specialty area, BPS will need the following:
Names and resumes of subject matter experts in the areas of Infectious Diseases and Cardiology Pharmacy; (10 individuals will be selected to serve on each Practice Analysis Task Force). However, in addition to these Task Force members, additional subject matter experts can assist BPS by participating in a telephone interview, an e-mail-based external review of documents developed by the relevant Task Force, or the pilot test of the related survey. The links to the Call for Nominations is below and self-nominations are welcomed from subject matter experts.
For Infectious Diseases - https://www.surveymonkey.com/s/InfectiousDiseasePharmacy
For Cardiology - https://www.surveymonkey.com/s/CardiologyPharmacy
Due Date for both Infectious Diseases and Cardiology Pharmacy Nominations: May 4, 2012.
BPS will announce the appointments on or about May 25, 2012.
- BPS will convene a 2-day meeting with the Infectious Diseases Practice Analysis Task Force on July 17-18, 2012, in Washington, DC, to create a preliminary content outline for this proposed specialty. Attendance by appointees to the Infectious Diseases Practice Analysis Task Force at this meeting is required. If you cannot attend this meeting and would like to be involved, please volunteer for one of the other activities outlined in the link above.
- BPS will then convene a 2-day meeting with the Cardiology Practice Analysis Task Force on July 23-24, 2012, in Washington, DC, to create a preliminary content outline for this proposed specialty. Attendance by appointees to the Cardiology Practice Analysis Taskforce at this meeting is required. If you cannot attend this meeting and would like to be involved, please volunteer for one of the other activities outlined in the link above.
About the Board of Pharmacy Specialties The Board of Pharmacy Specialties (BPS) is an autonomous Division of the American Pharmacists Association (APhA), founded in January 1976 to recognize specialties and certify pharmacists in specialized areas of pharmacy practice. Six specialties are currently recognized by BPS, including 1) nuclear pharmacy, since 1978; 2) nutrition support pharmacy, since 1988; pharmacotherapy, since 1988; psychiatric pharmacy, since 1992; oncology pharmacy, since 1996. The latest BPS specialty, focused on ambulatory care pharmacy, was approved in June 2009, and is scheduled for its first examination in 2011. More than 10,500 pharmacist specialists are currently certified by BPS.
